FindTrial
Sign In

A study to find whether a structured self management programme helps patients with drug resistant epilepsy take medicines regularly, feel more confident, and reduce health problems.

Effectiveness of Comprehensive Targeted Self Management of Drug Resistant Epilepsy on medication adherence, self-Efficacy and negative health events among patients diagnosed with drug resistant epilepsy at selected tertiary care hospital. - CoT-DRE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100627
Enrollment
40
Registered
2026-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G408- Other epilepsy and recurrent seizures

Interventions

Intervention1: Comprehensive targeted self management of drug resistant epilepsy (CoT-DRE): A structured, Comprehensive Targeted Self Management of Drug Resistant Epilepsy (CoT-DRE) focusing on patien

Sponsors

Self- funded (Mansi Sahu)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the adults patient with Drug Resistant Epilepsy of age group 18 to 70 years. Able to communicate verbally and agree to participate in the study. Had a diagnosis of epilepsy for atleast 1 year of duration. The patient who understands Hindi or English. Patient had stable clinical condition at the time of assessment.

Exclusion criteria

Exclusion criteria: Patient with significant psychiatric comorbidity illness. Patient with other systemic illness like Chronic kidney disease, chronic liver disease that affects mental state of the patient. Female pregnant patient diagnosed with Drug Resistant Epilepsy. An inability to complete relevant education and scale filling.

Design outcomes

Primary

MeasureTime frame
To assess the effectiveness of a Comprehensive Targeted Self-Management of Drug Resistant Epilepsy on medication adherence, self efficacy and negative health events among patients diagnosed with Drug Resistant Epilepsy attending Neurology OPD, KGMU, Lucknow.Timepoint: Baseline (pre-test) and after completion of intervention (post-test at 4 weeks).—

Secondary

MeasureTime frame
To find out association between selected Demographic variable & Medication Adherence among Drug Resistant Epilepsy patients.Timepoint: Data will be collected at baseline (pretest) using a structured demographic questionnaire & the Morisky Medication Adherence Scale (MMAS8) & medication adherence will again assess after 4 weeks by morisky medication adherence scale;To find out correlation between Self Efficacy scores & Quality of life scores among Drug resistant epilepsy patients.Timepoint: At post-test (after four weeks of intervention program)—

Countries

India

Contacts

Public ContactMansi Sahu

King George s Medical University (KGMU), KGMU College of Nursing

urvashi@kgmcindia.edu7317083604

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026